Zacchia Miriam, Di Iorio Valentina, Trepiccione Francesco, Caterino Marianna, Capasso Giovambattista
Division of Nephrology, Department of Cardiothoracic and Respiratory Sciences, University of Campania "Luigi Vanvitelli," Naples, Italy.
Eye Clinic, Multidisciplinary Department of Medical, Surgical, and Dental Sciences, University of Campania "Luigi Vanvitelli," Naples, Italy.
Kidney Dis (Basel). 2017 Jul;3(2):57-65. doi: 10.1159/000475500. Epub 2017 May 17.
The ciliopathies are a growing number of disorders caused by mutations in genes involved in the function of the primary cilium. Bardet-Biedl syndrome (BBS) belongs to this group of disorders. In this setting, kidney dysfunction is highly variable, and urine concentrating defect, a common feature of multiple ciliopathies, has been described as the most frequent defect. Here we review the mechanism of urine concentration and describe the possible mechanism underling this defect in ciliopathies and especially BBS, based on the current body of literature.
Active Na absorption along the thick ascending limb of the loop of Henle (TAL) is critical for generating the corticomedullary osmotic gradient, and the countercurrent anatomical arrangement of the 2 branches of the loop of Henle enhances this gradient. The vasa recta, paralleling the loop of Henle, operate into the countercurrent mechanism, minimizing washout of solutes from the interstitium. Final water reabsorption is mediated by the aquaporin 2 (AQP2) water channels along the distal nephron, and it is under hormonal control. Several studies demonstrated that hyposthenuria in BBS patients relies on kidney resistance to desmopressin, suggesting a renal origin. We recently showed that the majority of hyposthenuric BBS patients have also a defect regarding maximal urine dilution. Independent studies showed that deficiency caused AQP2 mistrafficking in vitro; accordingly, we demonstrated impaired urinary AQP2 excretion in BBS patients with combined concentrating and diluting defect. Whether receptor signaling pathways or downstream events cause AQP2 deregulation is still unclear. In addition, reduced urinary uromodulin excretion in BBS patients opens the possibility that TAL dysfunction may also play a pathogenic role.
Impaired water handling in BBS is associated with AQP2 mistrafficking. The potential role of additional factors, such as the dissipation of the medullary osmotic gradient due to TAL dysfunction and/or structural anomalies, remains to be elucidated.
纤毛病是由参与初级纤毛功能的基因突变引起的越来越多的疾病。巴德-比德尔综合征(BBS)属于这组疾病。在这种情况下,肾功能障碍差异很大,尿液浓缩缺陷是多种纤毛病的常见特征,已被描述为最常见的缺陷。在此,我们根据当前的文献综述尿液浓缩机制,并描述纤毛病尤其是BBS中这种缺陷的可能潜在机制。
沿髓袢升支粗段(TAL)的主动钠重吸收对于产生皮质-髓质渗透梯度至关重要,髓袢两个分支的逆流解剖结构增强了这种梯度。与髓袢平行的直小血管参与逆流机制,使间质中的溶质冲洗最小化。最终的水重吸收由远端肾单位的水通道蛋白2(AQP2)水通道介导,并受激素控制。多项研究表明,BBS患者的低渗尿依赖于肾脏对去甲加压素的抵抗,提示起源于肾脏。我们最近表明,大多数低渗性BBS患者在最大尿液稀释方面也存在缺陷。独立研究表明,缺陷在体外导致AQP2转运错误;因此,我们证明了合并浓缩和稀释缺陷的BBS患者尿AQP2排泄受损。受体信号通路或下游事件是否导致AQP2失调仍不清楚。此外,BBS患者尿调节蛋白排泄减少,提示TAL功能障碍也可能起致病作用。
BBS中水处理受损与AQP2转运错误有关。其他因素的潜在作用,如由于TAL功能障碍和/或结构异常导致的髓质渗透梯度消散,仍有待阐明。